Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

743
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
743
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

619
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
619
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

26
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
26

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active case-finding for TB in India: Assessment of scale and quality benchmarks, time taken and use of rapid molecular diagnostic tests.

PLOS global public health·2025
Same author

The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancer.

ESMO open·2025
Same author

OncoFlash: Research Updates in a Flash!

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Corrigendum: Investigation of advanced mindfulness meditation cessation experiences using EEG spectral analysis in an intensively sampled case study. [Neuropsychologia (2023) 190, 108694].

Neuropsychologia·2024
Same author

Functional Assessment of Stable Chronic Obstructive Pulmonary Disease Patients Using Squat-to-stand Test.

Mymensingh medical journal : MMJ·2024
Same author

OncoFlash-Research Updates in a Flash! (Mar 2024).

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Related Experiment Video

Updated: Mar 19, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.2K

Does active case finding detect TB early in programme settings? A national-level study in India.

H D Shewade1, S Kiran Pradeep1, P Ravichandran1

  • 1ICMR National Institute of Epidemiology (ICMR-NIE), Chennai, India.

Public Health Action
|March 18, 2026
PubMed
Summary

India

Keywords:
Indiacommunity-based systematic screeningearly detectionmarginalised populationstuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Mar 19, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.2K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Tuberculosis Control

Background:

  • India's national tuberculosis (TB) program employs active case finding (ACF) in high-risk groups since 2017.
  • The ACF strategy involves symptom screening and confirmatory testing to identify TB cases.

Purpose of the Study:

  • To compare pre-treatment delays and severity of illness at diagnosis between adults with drug-sensitive pulmonary TB detected through ACF and passive case finding (PCF).
  • To assess the effectiveness of ACF in reaching vulnerable populations and facilitating early TB detection.

Main Methods:

  • A cross-sectional analytical study was conducted in 28 randomly selected districts across India in 2023.
  • Data were collected from 790 adults diagnosed with drug-sensitive pulmonary TB, comparing 426 ACF-detected and 364 PCF-detected individuals.
  • Severe illness was defined by the presence of very severe undernutrition, respiratory insufficiency, or poor performance status.

Main Results:

  • ACF-detected adults were older, resided farther from healthcare facilities, had lower formal education, lower household income, and fewer healthcare provider visits compared to PCF-detected individuals.
  • Despite ACF reaching vulnerable populations, pre-treatment delays (median 46 days for both groups) and the burden of severe illness (39% vs. 34%) were similar between ACF and PCF groups.
  • ACF successfully linked vulnerable individuals to care, evidenced by reduced healthcare provider visits.

Conclusions:

  • Active case finding in India connects vulnerable populations to TB care but does not appear to shorten pre-treatment delays or reduce the severity of illness at diagnosis.
  • The high burden of severe illness observed at diagnosis in both ACF and PCF groups highlights a persistent challenge in early TB detection.
  • Further strategies are needed to improve timely diagnosis and reduce illness severity among high-risk populations targeted by TB programs.